Cancer, Advanced Active Not Recruiting Phase 2 Trials for Ipilimumab (DB06186)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

DBCOND0041606 (Cancer, Advanced)Active Not Recruiting2 IdentifierTitlePurposeDrugs
NCT02750514An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung CancerTreatment